Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-16

FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves the original generic application for Bupropion Hydrochloride SR, enabling Slate Run Pharmaceuticals to market a generic sustained-release antidepre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)